文献速递物质与行为成瘾心境障碍

酒精依赖与重性抑郁共病的遗传风险变异研究

Genetic Risk Variants Associated With Comorbid Alcohol Dependence and Major Depression.
PubMed 文献 · JAMA Psychiatry · 2017-01-01

该全基因组关联研究分析耶鲁-宾州研究中4653名非裔美国人和3169名欧洲裔美国人的酒精依赖与重性抑郁共病标准计数,发现SEMA3A基因座rs139438618在非裔美国人中显著且可重复地与共病相关,多基因风险评分分析揭示与神经质、抑郁症状、主观幸福感、教育程度及颅内和壳核体积的多效性。

要点

  • SEMA3A基因座rs139438618在非裔美国人中与酒精依赖和重性抑郁共病显著相关且可重复。
  • 欧洲裔美国人中未发现显著关联。
  • 多基因风险评分显示共病与神经质、抑郁症状、较低主观幸福感和教育程度及脑体积特征存在多效性。

核心结论

  • SEMA3A变异在非裔美国参与者中与酒精依赖和重性抑郁共病显著且可重复相关。
  • 多基因风险评分分析识别出与神经精神性状和脑体积的多效性。

研究设计与样本

  • 全基因组关联研究分析耶鲁-宾州研究中1999年2月14日至2015年1月13日收集的非裔美国人和欧洲裔美国人数据集。
  • 排除从未接触酒精或任何诊断标准信息缺失的参与者后,对耶鲁-宾州1和2两个样本共4653名非裔美国人和3169名欧洲裔美国人分别进行分析。
  • 共病标准计数为DSM-IV定义的酒精依赖7项标准和重性抑郁9项标准缩放至7项,范围0至14。

主要发现

  • 7822名参与者中(3342名女性,4480名男性;平均[SD]年龄40.1[10.7]岁),共病标准计数中位数为6.2(四分位距2.3-10.9)。
  • 在耶鲁-宾州1非裔美国样本中,SEMA3A位点rs139438618与共病显著相关(β=0.89;95%CI,0.57-1.20;P=2.76×10-8)。
  • 在独立耶鲁-宾州2样本中关联亦显著(β=0.83;95%CI,0.39-1.28;P=2.06×10-4),两样本荟萃分析关联更稳健(β=0.87;95%CI,0.61-1.12;P=2.41×10-11)。
  • 欧洲裔美国参与者中未发现显著关联。
  • 多基因风险评分分析显示神经质风险较高(β=1.01;95%CI,0.50-1.52)、抑郁症状风险较高(β=0.87;95%CI,0.32-1.42)、主观幸福感较低(β=-0.94;95%CI,-1.46至-0.42)、教育程度较低(β=-1.00;95%CI,-1.57至-0.44)、颅内体积较大(β=1.07;95%CI,0.50至1.64)和壳核体积较小(β=-1.16;95%CI,-1.86至-0.46)与共病水平较高相关。

临床怎么用

  • 在非裔美国人群中可考虑SEMA3A变异作为酒精依赖与重性抑郁共病的遗传风险标志。
  • 多基因风险评分涉及的神经质、抑郁症状、主观幸福感、教育程度及脑体积特征可能有助于识别共病高风险个体。

局限性

  • 研究未在欧洲裔美国参与者中识别出显著关联,提示遗传发现存在 ancestry 特异性。
  • 需进一步研究理解该共病的生物学和遗传机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Alcohol dependence (AD) and major depression (MD) are leading causes of disability that often co-occur. Genetic epidemiologic data have shown that AD and MD share a common possible genetic cause. The molecular nature of this shared genetic basis is poorly understood. OBJECTIVES: To detect genetic risk variants for comorbid AD and MD and to determine whether polygenic risk alleles are shared with neuropsychiatric traits or subcortical brain volumes. DESIGN, SETTING, AND PARTICIPANTS: This genome-wide association study analyzed criterion counts of comorbid AD and MD in African American and European American data sets collected as part of the Yale-Penn study of the genetics of drug and alcohol dependence from February 14, 1999, to January 13, 2015. After excluding participants never exposed to alcohol or with missing information for any diagnostic criterion, genome-wide association studies were performed on 2 samples (the Yale-Penn 1 and Yale-Penn 2 samples) totaling 4653 African American participants and 3169 European American participants (analyzed separately). Tests were performed to determine whether polygenic risk scores derived from potentially related traits in European American participants could be used to estimate comorbid AD and MD. MAIN OUTCOMES AND MEASURES: Comorbid criterion counts (ranging from 0 to 14) for AD (7 criteria) and MD (9 criteria, scaled to 7) as defined by the DSM-IV. RESULTS: Of the 7822 participants (3342 women and 4480 men; mean [SD] age, 40.1 [10.7] years), the median comorbid criterion count was 6.2 (interquartile range, 2.3-10.9). Under the linear regression model, rs139438618 at the semaphorin 3A (SEMA3A [OMIM 603961]) locus was significantly associated with AD and MD comorbidity in African American participants in the Yale-Penn 1 sample (β = 0.89; 95% CI, 0.57-1.20; P = 2.76 × 10-8). In the independent Yale-Penn 2 sample, the association was also significant (β = 0.83; 95% CI, 0.39-1.28; P = 2.06 × 10-4). Meta-analysis of the 2 samples yielded a more robust association (β = 0.87; 95% CI, 0.61-1.12; P = 2.41 × 10-11). There was no significant association identified in European American participants. Analyses of polygenic risk scores showed that individuals with a higher risk of neuroticism (β = 1.01; 95% CI, 0.50-1.52) or depressive symptoms (β = 0.87; 95% CI, 0.32-1.42) and a lower level of subjective well-being (β = -0.94; 95% CI, -1.46 to -0.42) and educational attainment (β = -1.00, 95% CI, -1.57 to -0.44) had a higher level of AD and MD comorbidity, while larger intracranial (β = 1.07; 95% CI, 0.50 to 1.64) and smaller putamen volumes (β = -1.16; 95% CI, -1.86 to -0.46) were associated with higher risks of AD and MD comorbidity. CONCLUSIONS AND RELEVANCE: SEMA3A variation is significantly and replicably associated with comorbid AD and MD in African American participants. Analyses of polygenic risk scores identified pleiotropy with neuropsychiatric traits and brain volumes. Further studies are warranted to understand the biological and genetic mechanisms of this comorbidity, which could facilitate development of medications and other treatments for comorbid AD and MD.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Zhou H, Polimanti R, Yang BZ, et al. Genetic Risk Variants Associated With Comorbid Alcohol Dependence and Major Depression. JAMA Psychiatry. 2017. PMID: 29071344. doi:10.1001/jamapsychiatry.2017.3275

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。